There is also hope that our nation is finally beginning to make the dementia public health crisis a priority. Over the past ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

“These new antibody treatments [lecanemab and donanemab] represent a defining moment in the history of treating Alzheimer’s disease and give much needed hope,” says Katherine Gray, the head of ...

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...

Formula 1 legend Sir Jackie Stewart started the charity Race Against Dementia (RAD) after his wife Lady Helen Stewart's ...

Discovery may offer new therapeutic target for development of new drugs against Alzheimer's and other neurodegenerative disorders.

New research into nursing home care for residents with Alzheimer's disease or related dementias found they frequently experience costly and burdensome treatments that do not align with their own care ...

Researchers hope the findings will reveal the causes of Parkinson’s and Parkinson’s dementia, why some brain cells are more ...

DLB is the second most common form of progressive dementia, affecting approximately 1.4 million people in the U.S., with no approved treatments available. DLB is caused by the buildup of a protein ...